Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.

Charles JA, Tremlett H, Lu E, Guimond C, Sadovnick AD.

Neurology. 2013 Mar 12;80(11):1068-9. doi: 10.1212/01.wnl.0000428359.07207.f6. Review.

PMID:
23479468
2.

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.

Lu E, Wang BW, Guimond C, Synnes A, Sadovnick D, Tremlett H.

Neurology. 2012 Sep 11;79(11):1130-5. doi: 10.1212/WNL.0b013e3182698c64. Epub 2012 Aug 29. Review.

3.

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.

Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pastò L, Razzolini L, Piscolla E, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, La Mantia L, Mancardi G, Solaro C, Totaro R, Tola MR, De Luca G, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP.

BMC Neurol. 2012 Oct 22;12:124. doi: 10.1186/1471-2377-12-124.

4.

[Disease modifying drugs in multiple sclerosis and pregnancy].

Tur C, Tintoré M, Aguilera C.

Med Clin (Barc). 2012 Sep 22;139(7):316-8. doi: 10.1016/j.medcli.2012.04.021. Epub 2012 Jun 27. Spanish. No abstract available.

PMID:
22743277
5.

Long-term effects of exposure to disease-modifying drugs in the offspring of mothers with multiple sclerosis: a retrospective chart review.

Fragoso YD, Adoni T, Alves-Leon SV, Azambuja ND Jr, Barreira AA, Brooks JB, Carneiro DS, Carvalho MJ, Claudino R, Comini-Frota ER, Domingues RB, Finkelzstejn A, Gama PD, Giacomo MC, Gomes S, Goncalves MV, Grzesiuk AK, Kaimen-Maciel DR, Mendes MF, Morales NM, Morales RR, Muniz A, Papais-Alvarenga RM, Parolin MK, Ribeiro SB, Ruocco HH, Siquineli F, Tosta ED.

CNS Drugs. 2013 Nov;27(11):955-61. doi: 10.1007/s40263-013-0113-7.

PMID:
24114585
6.

Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study.

Weber-Schoendorfer C, Schaefer C.

Mult Scler. 2009 Sep;15(9):1037-42. doi: 10.1177/1352458509106543.

PMID:
19692433
7.

The Brazilian database on pregnancy in multiple sclerosis.

Finkelsztejn A, Fragoso YD, Ferreira ML, Lana-Peixoto MA, Alves-Leon SV, Gomes S, Damasceno BP, Mendes MF, Salgado PR, Correa EC, Comini-Frota ER, Diniz DS, Gama PD, Kaimen-Maciel DR, Morales RR, Arruda WO, Grzesiuk AK, Khouri JM, Lopes JS, Rocha CF, Domingues R, Gonçalves MV, Lorenti MA, Parolin MK, Siquineli F, Tosta ED, Brooks JB, Gallina AS, Melges LD, Ruocco HH.

Clin Neurol Neurosurg. 2011 May;113(4):277-80. doi: 10.1016/j.clineuro.2010.11.016. Epub 2010 Dec 15.

PMID:
21159421
8.

Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes.

Salminen HJ, Leggett H, Boggild M.

J Neurol. 2010 Dec;257(12):2020-3. doi: 10.1007/s00415-010-5652-y. Epub 2010 Jul 13.

PMID:
20625758
9.

Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs.

Lu E, Dahlgren L, Sadovnick A, Sayao A, Synnes A, Tremlett H.

Mult Scler. 2012 Apr;18(4):460-7. doi: 10.1177/1352458511422244. Epub 2011 Sep 13.

PMID:
21914689
10.

Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.

Lu E, Wang BW, Guimond C, Synnes A, Sadovnick AD, Dahlgren L, Traboulsee A, Tremlett H.

Expert Rev Neurother. 2013 Mar;13(3):251-60; quiz 261. doi: 10.1586/ern.13.12. Review.

PMID:
23448215
11.

Interferon beta babies.

Waubant E, Sadovnick AD.

Neurology. 2005 Sep 27;65(6):788-9. No abstract available.

PMID:
16186513
12.

Multiple sclerosis: management issues during pregnancy.

Ferrero S, Pretta S, Ragni N.

Eur J Obstet Gynecol Reprod Biol. 2004 Jul 15;115(1):3-9. Review.

PMID:
15223156
13.

Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.

Ghezzi A, Annovazzi P, Portaccio E, Cesari E, Amato MP.

Expert Rev Clin Immunol. 2013 Jul;9(7):683-91; quiz 692. doi: 10.1586/1744666X.2013.811046. Review.

PMID:
23899239
14.

Glatiramer acetate in multiple sclerosis.

Mezzapesa DM, Rovaris M, Filippi M.

Expert Rev Neurother. 2005 Jul;5(4):451-8. Review.

PMID:
16026228
15.

Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis.

Sandberg-Wollheim M, Frank D, Goodwin TM, Giesser B, Lopez-Bresnahan M, Stam-Moraga M, Chang P, Francis GS.

Neurology. 2005 Sep 27;65(6):802-6. Epub 2005 Aug 10. Review.

PMID:
16093457
16.

Cost effectiveness of glatiramer acetate and natalizumab in relapsing-remitting multiple sclerosis.

Earnshaw SR, Graham J, Oleen-Burkey M, Castelli-Haley J, Johnson K.

Appl Health Econ Health Policy. 2009;7(2):91-108. doi: 10.2165/11314900-000000000-00000.

PMID:
19731967
17.

Antidepressant use during pregnancy: a critical systematic review of the literature.

Simoncelli M, Martin BZ, Bérard A.

Curr Drug Saf. 2010 Apr;5(2):153-70. Review.

PMID:
19534639
18.

Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.

Comi G, Cohen JA, Arnold DL, Wynn D, Filippi M; FORTE Study Group..

Ann Neurol. 2011 Jan;69(1):75-82. doi: 10.1002/ana.22316.

PMID:
21280077
19.

Glatiramer acetate: successful desensitization for treatment of multiple sclerosis.

Bains SN, Hsieh FH, Rensel MR, Radojicic C, Katz HT, Inamdar SR, Lang DM.

Ann Allergy Asthma Immunol. 2010 Apr;104(4):321-5. doi: 10.1016/j.anai.2009.11.040.

PMID:
20408342
20.

Effects of prenatal exposure to cigarette smoke on use of xanthine and pneumogram evaluation at discharge in premature infants.

Jeliazkova Z, Razi N, Saslow J, Amendolia B, Stahl G, Pyon K, Bhat V, Kemble N, Aghai ZH.

J Matern Fetal Neonatal Med. 2012 Jun;25(6):766-9. doi: 10.3109/14767058.2011.587558. Epub 2011 Oct 1.

PMID:
21961800

Supplemental Content

Support Center